News

Nominations are now being accepted for an ISHLT award to recognize and reward the mentors among its membership. Nominations for the ISHLT Francis D. Pagani, MD Endowed Mentorship Award will be accepted until 20 January, 2026 at 11:59 p.m. ET / 21 January, 2026 at 03:59 UTC.

First author Muhtadi Alnababteh, MD, and senior author Michael Keller, MD, are on the podcast this month to discuss their paper, “Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.”

ISHLT unites a global, multidisciplinary community to advance research, education, and innovation in the care of patients with advanced heart and lung disease. Hear from your peers how they are able to connect and collaborate globally to advance the field.

The Journal of Heart and Lung Transplantation (JHLT), an official publication of the ISHLT, will release a special issue in March 2026 dedicated to manuscripts exploring device therapies in advanced heart and lung disease. Submissions for this issue are now being accepted until Tuesday, 30 December, 2025.

Registration rates and policies for ISHLT2026, ISHLT Academies, and Preconference Day events are now available. As always, rates differ depending on your membership status and country of practice. Registration will open in mid-December 2025.

The International Society for Heart & Lung Transplantation (ISHLT) will host a joint Lung Tranplant Symposium with the Society of Thoracic Surgeons (STS) at the 62nd STS Annual Meeting on 29 January, 2026 in New Orleans, LA USA.

In October's ISHLT Journal Watch, transplant pathologists review recent literature on dd-cf-DNA, CAV, and ALAD.

The International Society for Heart and Lung Transplantation (ISHLT) has announced the results of its 2026 elections, confirming a new leadership team for the Board of Directors and Professional Community Representatives.

Hear from your peers how involvement in ISHLT has opened doors and advanced careers in this video. ISHLT is the one Society that connects you to the global, multidisciplinary people and programs focused on advancing the science and standards of care for advanced heart and lung disease.

A new ISHLT Document, ISHLT Consensus Statement on the Perioperative Use of ECLS in Lung Transplantation: Part I - Preoperative Considerations, has been published in JHLT and is available to read online!

The ISHLT’s 46th Annual Meeting & Scientific Sessions will take place in Toronto, ON Canada in April 2026. If you plan to attend ISHLT2026, please review the following important travel information and take any necessary next steps to ensure you’ll be able to join in Toronto.

Nir Uriel, MD of New York Presbyterian Hospital and Columbia University appears on JHLT: The Podcast to discuss the work of the Cardiogenic Shock Working Group and their recent paper on the outcomes of patients supported on Impella 5.5 .

During the 36th Annual Extracorporeal Life Support Organization (ELSO) Conference in Oxon, Hill MD USA, the ISHLT and ELSO hosted a joint breakout session, Maximizing the Donor Pool: ECMO-Driven Advanced in Cardiothoracic Transplantation.

A new ISHLT Document, ISHLT Consensus Statement on the Referral and Selection of Pediatric Lung Transplant Candidates, has been published in JHLT and is available to read online.

The ISHLT2026 Call for Abstracts submission site closes next week. Don’t delay – submit your best science in advanced heart and lung failure and transplantation, mechanical circulatory support, and pulmonary vascular disease by Tuesday, 14 October at 11:59 p.m. ET/Wednesday, 15 October at 03:59 UTC.

ISHLT will host a joint educational workshop, Current Status of Heart and Lung Allocation, with the Associação Brasileira de Transplantes de Órgãos (ABTO) at the Pre-Congress of their 2025 Annual Congress.

Next month, a webinar from Natera will bring together leading transplant experts to unveil the latest findings from the DEFINE-HT study and explore the clinical utility of donor-derived cell-free DNA with Donor Quantity Score in heart transplantation.

In response to the Organ Procurement and Transplantation Network (OPTN) annual summer call for public comments, the ISHLT has submitted official comments on four OPTN proposals.

Dr. Ayumi Goda of Kyorin University Hospital in Tokyo appears on JHLT: The Podcast to discuss her team's study on unmasking occult HFpEF in pulmonary hypertension patients.

In September's ISHLT Journal Watch, cardiothoracic surgeons review recent literature on DCD heart transplant, lung transplant, and xenotransplantation.